Event
PFS & Injectable Drug Devices East Coast
April 27 - April 29
PFS East coast 2026 conference will bring together top experts, industry leaders, and innovators for a three-days of key insights and networking, featuring a comprehensive pre-conference focus day dedicated to advancements in device design, followed by a dynamic two-day main conference featuring keynote plenaries, interactive panel discussions, and specialized topic streams covering the most pressing industry challenges and breakthrough solutions.
Cambridge Consultants is hosting a roundtable discussion on the focus day, if you are attending or would like to participate please come and join us:
Date: 27th April
Time: 16:30
Speaker: Philip Canner, Head of Drug Delivery at Cambridge Consultants
Title: Commercial Perspective: Optimizing External Collaboration in Injectable Drug Delivery
- How pharma companies can build strategic partnerships with CDMOs and device developers to streamline product development, drive innovation, and enable scalability
- Strategies to harmonize goals and operations, fostering resilient, high-performance collaborations that deliver sustainable value
Date: 28th April
Speaker: Charlie Dean, Head of Sustainable Medical Technology at Cambridge Consultants
Title: Sustainability Where it Matters: Using Devices to Bring the Clinic to the Patient
- Radical sustainability through long-term platform design
- Using a case study of a novel implantable drug delivery technology, DARE-IDDS
- Showing why changing the care pathway through device innovation delivers significantly higher carbon savings than incremental improvements
Talk to the team
Philip Canner
With over twenty years' experience in medical device leadership, engineering, and management consultancy, Philip has led the development of an extensive range of medical technologies, with a particular focus on drug delivery.
Charlie Dean
Charlie is the Head of Sustainable Medical Technology with expertise in mechanical design and analytical methods in medical device development. He is a LCA practitioner who leads evaluation and design of medical products to drive environmental impact mitigation activities and for the circular economy.
Mohammad Hassan
Mohammad works with pharmaceutical and medtech teams to rethink how therapies reach patients - moving beyond the clinic into everyday life. He focuses on decentralizing care, reducing clinical burden while putting control back into patients’ hands.